Leduc R, Hendy G N, Seidah N G, Chrétien M, Lazure C
J.A. de Sève Laboratories of Molecular Neuroendocrinology, Clinical Research Institute of Montreal, Québec, Canada.
Life Sci. 1990;46(20):1427-33. doi: 10.1016/0024-3205(90)90458-4.
Chromogranin A has been reported to be processed in vivo by an as yet undefined proteinase(s) suggesting that it is a precursor of biologically active peptides such as pancreastatin. In this study, plasma kallikrein was used as a model proteinase to identify the cleavage sites exposed in bovine parathyroid chromogranin A. Purified bovine parathyroid chromogranin A was digested with human plasma kallikrein. The proteolytic fragments produced were isolated by HPLC and chemically characterized by amino acid composition and sequence analysis. The combined results indicate that the enzyme has preference for specific single Arg residues, cutting C-terminal to this amino acid, although certain pairs of basic sites were also cleaved. The characterized fragments were released in a selective manner from the whole molecule with rapid production of the fragments covering positions 1-247 and 352-358.
据报道,嗜铬粒蛋白A在体内会被一种尚未明确的蛋白酶加工处理,这表明它是诸如胰抑制素等生物活性肽的前体。在本研究中,血浆激肽释放酶被用作模型蛋白酶,以确定牛甲状旁腺嗜铬粒蛋白A中暴露的切割位点。用人类血浆激肽释放酶消化纯化的牛甲状旁腺嗜铬粒蛋白A。通过高效液相色谱法分离产生的蛋白水解片段,并通过氨基酸组成和序列分析对其进行化学表征。综合结果表明,该酶对特定的单个精氨酸残基具有偏好性,在该氨基酸的C末端进行切割,不过某些碱性位点对也会被切割。所表征的片段以选择性方式从整个分子中释放出来,快速产生覆盖第1 - 247位和第352 - 358位的片段。